跳至主要内容
临床试验/NL-OMON45429
NL-OMON45429已完成不适用

ymphadenectomy in urothelial carcinoma in the renal pelvis and ureter - A randomized international clinical trial on lymphadenectomy in urothelial carcinoma in the renal pelvis and ureter - Lymphadenectomy in urothelial carcinoma in the renal pelvis and ureter

Zealand University Hospital0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • -written informed consent
  • -age >17 years
  • -Eastern Cooperative Oncology Group (ECOG) performance status 0-2;All patients need at least one criterium of A and one of B.
  • A. Histological defined upper tract urothelial carcinoma (UTUC): histologically confirmed diagnosis of predominantly urothelial carcinoma of the upper tract.
  • 1. Positive biopsy for high grade tumor
  • 2. Selective upper tract positive cytology
  • 3. Micturition positive cytology (if there is no bladder cancer simultaneously);B. Radiological defined UTUC: patients with UTUC cT2-T4, N0-M0 (TNM classification). Criteria must be defined by radiologists;Pelvic of calyx tumor:
  • 1. Absence of fat between pelvis and kidney
  • 2. Evidence of parenchymal invasion
  • 3. Growing of tumour out of the renal pelvis
  • 4. Tumor >1 cm;Upper 2/3 of ureter:
  • 1. growing of the tumour out of the ureter
  • 2. dilation grade 3-4
  • 3. tumor >1 cm

排除标准

  • -Clinical suspicion of non-muscle invasive UTUC
  • -Metastatic urothelial carcinoma for the renal pelvis or upper 2/3 of the ureter
  • -Radiological positive lymph nodes in the retroperitoneal region

研究者

相似试验